Fig 3. Receiver operating characteristic curve comparing the baseline neutrophil-to-lymphocyte ratio (NLR), NLR at week 14, white blood cell (WBC) count, and the neutrophil count for predicting LOR to infliximab in patients with ulcerative colitis (UC).

Baseline NLR: area under the curve (AUC) = 0.798, NLR at week 14: AUC = 0.702, WBC count: AUC = 0.627, neutrophil count: AUC = 0.736.